Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Kristjan Sigurdsson"'
Autor:
Cecilie Dovey de la Cour, Sonia Guleria, Mari Nygård, Laufey Trygvadóttir, Kristjan Sigurdsson, Kai‐Li Liaw, Maria Hortlund, Camilla Lagheden, Bo T. Hansen, Christian Munk, Joakim Dillner, Susanne K. Kjaer
Publikováno v:
Cancer Medicine, Vol 8, Iss 2, Pp 839-849 (2019)
Abstract It is valuable to establish a population‐based prevaccination baseline distribution of human papillomavirus (HPV) types among women with high‐grade cervical intraepithelial neoplasia (CIN) grade 2 or 3 and cervical cancer in order to ass
Externí odkaz:
https://doaj.org/article/876c6341eeab4b5b81524e5459eb6a51
Autor:
Christian Munk, Camilla Lagheden, Sonia Guleria, Cecilie Dovey de la Cour, Laufey Trygvadóttir, Kristjan Sigurdsson, Joakim Dillner, Kai Li Liaw, Maria Hortlund, Susanne K. Kjaer, Bo T. Hansen, Mari Nygård
Publikováno v:
Dovey de la Cour, C, Guleria, S, Nygård, M, Trygvadóttir, L, Sigurdsson, K, Liaw, K-L, Hortlund, M, Lagheden, C, Hansen, B T, Munk, C, Dillner, J & Kjaer, S K 2019, ' Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention ', Cancer Medicine, vol. 8, no. 2, pp. 839-849 . https://doi.org/10.1002/cam4.1961
Cancer Medicine
Cancer Medicine
Publisher's version (útgefin grein)
It is valuable to establish a population‐based prevaccination baseline distribution of human papillomavirus (HPV) types among women with high‐grade cervical intraepithelial neoplasia (CIN) grade 2 or 3 an
It is valuable to establish a population‐based prevaccination baseline distribution of human papillomavirus (HPV) types among women with high‐grade cervical intraepithelial neoplasia (CIN) grade 2 or 3 an
Autor:
O-E Iversen, Kristjan Sigurdsson, Joakim Dillner, Mark T. Esser, Jorma Paavonen, Frank J. Taddeo, Janine T. Bryan, S-E Olsson, Scott Vuocolo, F. X. Bosch, Slawomir Majewski, Eliav Barr, Margaret James, Katherine E.D. Giacoletti, Susanne K. Kjaer, N. Munoz
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 23:1147-1155
Background Quadrivalent human papillomavirus (HPV types 6/11/16/18) L1 VLP vaccine is highly effective in preventing HPV 6/11/16/18-related cervical and external genital disease. Herein, we evaluated the impact of the quadrivalent HPV 6/11/16/18 L1 V
Autor:
Thorbjorg Gudmundsdottir, Rafn Sigurdsson, Helgi Sigvaldason, Kristjan Sigurdsson, Haraldur Briem
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 88:27-35
Evaluate the efficacy of catch-up HPV vaccination in sexually active young women and the potential impact of HPV vaccines on the practice of organized screening.(1) Women enrolled in the Future II study and (2) from a separate population-based study
Autor:
Lisa Lupinacci, Eliav Barr, Janine T. Bryan, Kristjan Sigurdsson, Susanne K. Kjaer, Teresa M. Hesley, Finn Egil Skjeldestad, Mauricio Hernández-Ávila, Annemarie R. Thornton, Joakim Dillner, John W. Boslego, Luisa L. Villa, Nubia Muñoz, Evan R. Myers, Steinar Thoresen, Gonzalo Perez, Sven Eric Olsson, Heather L. Sings, Christine K. Gause, Matti Lehtinen, Slawomir Majewski, F. Xavier Bosch, Mark T. Esser, Frank J. Taddeo, Jorma Paavonen, Kevin A. Ault, Patricia J. Garcia, Laura A. Koutsky, Darron R. Brown, Robert J. Kurman, Daron G. Ferris, Hseon Tay Eng
Publikováno v:
New England Journal of Medicine. 356:1915-1927
Human papillomavirus types 16 (HPV-16) and 18 (HPV-18) cause approximately 70% of cervical cancers worldwide. A phase 3 trial was conducted to evaluate a quadrivalent vaccine against HPV types 6, 11, 16, and 18 (HPV-6/11/16/18) for the prevention of
Autor:
Kristjan Sigurdsson, Helgi Sigvaldason
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 85:350-358
Cytological preinvasive changes are important precursors in cervical cancer, therefore variations in their trends affect screening guidelines.Trends in cytological preinvasive changes following the 1st to 5th screening visits in the 20-34 and 35-69 y
Autor:
Kristjan Sigurdsson, Helgi Sigvaldason
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 85:343-349
Few data are available on screening programs for cervical cancer that cover an entire nation over a prolonged period. The authors reviewed the findings of nationwide screening in Iceland over nearly 4 decades. Earlier analyses led to recommendations
Autor:
Helgi Sigvaldason, Kristjan Sigurdsson
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 85:359-365
Trends in CIN 2-3+ lesions affect the choice of target age group and screening interval.The following analyses were performed for CIN 2-3+ following 1st to 5th screening visits in the 20-34/35-69 age groups during 1979-2002: a) the relative risk of a
Publikováno v:
Breast cancer (Dove Medical Press). 5
Kristjan Sigurdsson,1,3 Elínborg Jóna Ólafsdóttir,21The Icelandic Cancer Detection Clinic, 2The Icelandic Cancer Registry, Icelandic Cancer Society, 3Faculty of Medicine, University of Iceland, Reykjavik, IcelandObjective: This study analyzes the
Publikováno v:
International Journal of Cancer. 94:884-888
Our aim was to study the effect, during the period 1979-1996, of the potential risk factors (i) year, age at second visit and first screening interval on the frequency of detection of low- and high-grade smears at the second visit after a normal smea